Mortality Risk for Patients with Cytomegalovirus Retinitis and Acquired Immune Deficiency Syndrome
Open Access
- 15 November 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (10) , 1365-1373
- https://doi.org/10.1086/379077
Abstract
We prospectively followed up 589 patients to evaluate the relationship of anti-cytomegalovirus (CMV) treatment and immune reconstitution in responseKeywords
This publication has 56 references indexed in Scilit:
- Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survivalAIDS, 1996
- Clinical Manifestations of AIDS in the Era of Pneumocystis ProphylaxisNew England Journal of Medicine, 1993
- Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with ZidovudineThe Journal of Infectious Diseases, 1992
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survivalJournal of Infection, 1991
- Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnetAIDS, 1991
- Longitudinal Study of Cytomegalovirus Retinitis in Acquired Immune Deficiency SyndromeOphthalmology, 1990
- Survival of Patients with the Acquired Immune Deficiency Syndrome after Development of Cytomegalovirus RetinopathyOphthalmology, 1990